SCLC Case Study

This page documents the case log for Coetta Lampe.

On July 4 2004, I arrived at her home in Oklahoma. She was chair ridden, extremely exhausted, and unable to care for herself.

I spent about a week researching cancer technology, and designed this treatment program:

Electroporation Potentiated Vitamin C + Lipoic Acid – The expected outcome based on research data and patents used is that the combination of IV Vitamin C, lipoic acid, and electroporation technology should moderate propagation and accelerate apoptosis of SCLC cells.

We implemented the program for the next four months. Use of the electroporation was delayed for three weeks.

We maintained a daily case-log indicating progress, compliance, and quality of life indicators, indexed against clinical indicators from blood tests.

Actual Outcome are documented in: Case Log - html and spreadsheet format: Case Log – Excel Format
The therapeutic outcome appears to be consistent with the expected outcome. Within about four months of therapy, the patient’s tumor markers had returned to slightly elevated levels, and there was no sign of cancer.
In the CaseLogThe Median Chart page clearly indicates a progressive decline of CEA tumor marker from June 59.2, to 8. During this there was a corresponding improvement in quality of life, physical appearance and energy. February 2005 she returned to work.
From December to February she progressively ceased all alternative therapies, intravenous vitamin C, oral lipoic acid, and electroporation therapy. Within two months, by April the tumors had started to grow again.
She returned to conventional care and high-dose chemotherapy. Tumor growth proceeded rapidly, and she passed away on July 30, 2005.